100 related articles for article (PubMed ID: 7655388)
1. Costs of introducing autologous BMT in the treatment of lymphoma and acute leukaemia in The Netherlands.
Uyl-de Groot CA; Okhuijsen SY; Hagenbeek A; Huijgens PC; van Imhoff GW; Löwenberg B; Verdonck LF; Rutten FF
Bone Marrow Transplant; 1995 Apr; 15(4):605-10. PubMed ID: 7655388
[TBL] [Abstract][Full Text] [Related]
2. [Costs of autologous bone marrow transplantation in non-Hodgkin lymphoma and acute leukemia].
Uyl-de Groot CA; Rutten FF
Ned Tijdschr Geneeskd; 1994 Jan; 138(1):28-31. PubMed ID: 8289955
[TBL] [Abstract][Full Text] [Related]
3. Comparative cost of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukaemia in first remission.
Dufoir T; Saux MC; Terraza B; Marit G; Guessard S; Foulon G; Reiffers J
Bone Marrow Transplant; 1992 Oct; 10(4):323-9. PubMed ID: 1422487
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of allogeneic bone marrow transplantation in patients with poor prognosis non-Hodgkin's lymphoma.
Bernard M; Dauriac C; Drénou B; Leberre C; Branger B; Fauchet R; Le Prisé PY; Lamy T
Bone Marrow Transplant; 1999 Feb; 23(4):329-33. PubMed ID: 10100576
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of ABMT in comparison with CHOP chemotherapy in patients with intermediate- and high-grade malignant non-Hodgkin's lymphoma (NHL).
Uyl-de Groot CA; Hagenbeek A; Verdonck LF; Löwenberg B; Rutten FF
Bone Marrow Transplant; 1995 Sep; 16(3):463-70. PubMed ID: 8535321
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma.
de Lima M; van Besien KW; Giralt SA; Khouri IF; Mehra R; Andersson BS; Przepiorka D; Gajewski JL; Korbling M; Champlin RE
Bone Marrow Transplant; 1997 Jan; 19(2):121-7. PubMed ID: 9116608
[TBL] [Abstract][Full Text] [Related]
7. The treatment of relapsed or refractory intermediate grade non-Hodgkin's lymphoma with autologous bone marrow transplantation followed by cyclosporine and interferon.
Gryn J; Johnson E; Goldman N; Devereux L; Grana G; Hageboutros A; Fernandez E; Constantinou C; Harrer W; Viner E; Goldberg J
Bone Marrow Transplant; 1997 Feb; 19(3):221-6. PubMed ID: 9028549
[TBL] [Abstract][Full Text] [Related]
8. Autologous bone marrow transplantation for haematological malignancies--experiences of the centre of Zagreb.
Nemet D; Labar B; Bogdanic V; Skodlar J; Petrovecki M; Mrsic M; Maravic N; Sneller V; Radman I; Kovacevic-Metelko J
Wien Med Wochenschr; 1995; 145(2-3):61-4. PubMed ID: 7762256
[TBL] [Abstract][Full Text] [Related]
9. Cost determinants in aggressive non-Hodgkin's lymphoma.
van Agthoven M; Sonneveld P; Verdonck LF; Uyl-de Groot CA
Haematologica; 2005 May; 90(5):661-71. PubMed ID: 15921381
[TBL] [Abstract][Full Text] [Related]
10. [Bone marrow transplantation versus maintenance chemotherapy for adult acute leukemia in first remission].
Suzuki R; Iida H; Taji H; Murata M; Sugihara T; Minami S; Kodera Y
Rinsho Ketsueki; 1996 Dec; 37(12):1362-70. PubMed ID: 8997123
[TBL] [Abstract][Full Text] [Related]
11. Myelodysplasia and acute leukemia following high-dose chemotherapy and autologous bone marrow or peripheral blood stem cell transplantation.
Sobecks RM; Le Beau MM; Anastasi J; Williams SF
Bone Marrow Transplant; 1999 Jun; 23(11):1161-5. PubMed ID: 10382956
[TBL] [Abstract][Full Text] [Related]
12. [Autologous stem-cell transplantations in children with non-Hodgkin lymphomas].
Wójcik B; Kowalczyk JR; Chybicka A; Wachowiak J; Drabko K; Zaucha-Prazmo A; Choma M; Gorczyńska E; Toporski J; Turkiewicz D; Kałwak K; Pieczonka A; Boruczkowski D
Przegl Lek; 2004; 61 Suppl 2():53-6. PubMed ID: 15686047
[TBL] [Abstract][Full Text] [Related]
13. Cost analysis of HLA-identical sibling and voluntary unrelated allogeneic bone marrow and peripheral blood stem cell transplantation in adults with acute myelocytic leukaemia or acute lymphoblastic leukaemia.
van Agthoven M; Groot MT; Verdonck LF; Löwenberg B; Schattenberg AV; Oudshoorn M; Hagenbeek A; Cornelissen JJ; Uyl-de Groot CA; Willemze R
Bone Marrow Transplant; 2002 Aug; 30(4):243-51. PubMed ID: 12203141
[TBL] [Abstract][Full Text] [Related]
14. [Intensive post-remission therapy in acute myeloid leukemia. Results of a prospective comparative study by the South Germany Hemoblastosis Group].
Hübner G; Link H; Schönrock-Nabulsi P; Wandt H; Gramatzki M; Löffler B; Fackler-Schwalbe I; Queisser W; Brack N; Geer T; Raab M; Ohl S; Schneider B; Schneider C; Freund M; Poliwoda H; Ehninger G
Med Klin (Munich); 1996 Apr; 91 Suppl 3():26-32. PubMed ID: 8692115
[TBL] [Abstract][Full Text] [Related]
15. [The bone-marrow transplantation program in Hungary: report from the period 1990-1995].
Petrányi G; Masszi T; Tímár L; Kriván G; Pálóczi K; Nagy K; Fekete S; Reményi P; Torbágyi E; Dénes R; Kelemen E
Orv Hetil; 1996 Oct; 137(40):2203-8. PubMed ID: 8927370
[TBL] [Abstract][Full Text] [Related]
16. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
Schütt P; Passon J; Ebeling P; Welt A; Müller S; Metz K; Moritz T; Seeber S; Nowrousian MR
Eur J Haematol; 2007 Feb; 78(2):93-101. PubMed ID: 17313557
[TBL] [Abstract][Full Text] [Related]
17. High-dose therapy and autologous bone marrow transplantation for intermediate and high grade non-Hodgkin's lymphoma in patients aged 55 years and over: results from the European Group for Bone Marrow Transplantation. The EBMT Lymphoma Working Party.
Sweetenham JW; Pearce R; Philip T; Proctor SJ; Mandelli F; Colombat P; Goldstone AH
Bone Marrow Transplant; 1994 Dec; 14(6):981-7. PubMed ID: 7711677
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic bone marrow transplantation in children failing prior autologous bone marrow transplantation.
Hale GA; Tong X; Benaim E; Cunningham JM; Heslop HE; Horwiz EM; Leung W; Rochester RJ; Shearer PD; Srivastava DK; Woodard JP; Bowman LC
Bone Marrow Transplant; 2001 Jan; 27(2):155-62. PubMed ID: 11281384
[TBL] [Abstract][Full Text] [Related]
19. [Hematopoietic stem cell transplantation for treatment of acute leukemia].
Harada M
Gan To Kagaku Ryoho; 1999 Sep; 26(10):1387-95. PubMed ID: 10500524
[TBL] [Abstract][Full Text] [Related]
20. Autologous PBSC transplant for late onset AML after mafosfamide-purged and TBI-containing autologous BMT.
Bassan R; Cortelazzo S; Rambaldi A; Cornelli P; Borleri G; Bellavita P; Biondi A; Barbui T
Bone Marrow Transplant; 1995 May; 15(5):791-3. PubMed ID: 7670409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
